CSF2 and neoplasm: Monocytes treated with tumor-derived microvesicles in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-4 retained CD14 but showed reduced surface expression of HLA II, while costimulatory molecules CD80 and CD86 were not upregulated (64).